Related Experiment Video
Updated: Mar 5, 2026

10:14
Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
4.3K
Macular Edema of Choroidal Origin.
1Hotel Dieu de Paris, Université Paris V Centre, Paris, France.
Developments in Ophthalmology
|March 29, 2017
Summary
Macular edema involves fluid buildup in the retina, often caused by abnormal choroidal new vessels in age-related macular degeneration. This leakage, influenced by vascular endothelial growth factor (VEGF) and cytokines, leads to retinal thickening.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Molecular Biology
Background:
- Macular edema (ME) is characterized by serous fluid accumulation and retinal thickening.
- Exudative age-related macular degeneration involves fluid leakage from choroidal new vessels, contributing to ME.
- Mechanisms include abnormal vessel permeability, inflammation, and cellular dysfunctions, particularly in Müller cells.
Purpose of the Study:
- To elucidate the mechanisms underlying macular edema formation in the context of choroidal neovascularization.
- To explore the roles of vascular endothelial growth factor (VEGF) and cytokines in fluid accumulation.
Main Methods:
- Clinical definition of macular edema.
- Pathophysiological analysis of fluid accumulation in exudative age-related macular degeneration.
- Investigation of cellular and molecular signaling pathways involved.
Main Results:
- Choroidal new vessels are a primary source of fluid leakage causing ME.
- Abnormal permeability and inflammation are key contributors to fluid accumulation.
- Müller cell dysfunction and metabolic alterations occur alongside choroidal neovascularization (CNV).
- Vascular endothelial growth factor (VEGF) plays a significant role in leakage, potentially preceded by cytokine signaling.
Conclusions:
- Macular edema pathogenesis involves complex interactions between vascular leakage, inflammation, and cellular responses.
- Cytokines may initiate or modulate VEGF-driven signaling pathways in ME.
- Understanding these pathways is crucial for developing targeted therapies for conditions like age-related macular degeneration.

